Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease

Background: Cerebrospinal fluid (CSF) platelet‐derived growth factor receptor‐β (PDGFRβ) has been proposed as a biomarker of blood–brain barrier (BBB) breakdown. We studied PDGFRβ levels as a biomarker for cerebral amyloid angiopathy (CAA), amnestic mild cognitive impairment (aMCI), or Alzheimer...

Descripción completa

Detalles Bibliográficos
Autores principales: De Kort, Anna M., Kuiperij, H. Bea, Kersten, Iris, Versleijen, Alexandra A.M., Schreuder, Floris H.B.M., Van Nostrand, William E., Greenberg, Steven M., Klijn, Catharina J.M., Claassen, Jurgen A.H.R., Verbeek, Marcel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787758/
https://www.ncbi.nlm.nih.gov/pubmed/34874603
http://dx.doi.org/10.1002/alz.12506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787758/
https://www.ncbi.nlm.nih.gov/pubmed/34874603
http://dx.doi.org/10.1002/alz.12506

Ejemplares similares